{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:43:19Z","timestamp":1793655799171,"version":"4.5.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017584","name":"SRM Institute of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017584","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.compbiolchem.2025.108690","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T18:35:32Z","timestamp":1758134132000},"page":"108690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P2","title":["Targeting Aurora A kinase: Computational discovery of potent inhibitors through integrated pharmacophore and simulation approaches"],"prefix":"10.1016","volume":"120","author":[{"given":"Bhuvaneswari","family":"Sivaraman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathiravan","family":"Muthukumaradoss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiolchem.2025.108690_bib1","series-title":"Cancer Chemotherapy. Treasure Island (FL)","author":"Amjad MT","year":"2023"},{"key":"10.1016\/j.compbiolchem.2025.108690_bib2","first-page":"6547","article-title":"Computational identification and molecular characterization of novel Aurora-B kinase inhibitors: pharmacophore modeling, docking, and molecular dynamics simulations","volume":"0","author":"Anand Selvam","year":"2025","journal-title":"Innov. Med. Omic."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib3","unstructured":"Annual Report to the Nation 2025: Overall Cancer Statistics [WWW Document], 2025. URL \u3008https:\/\/seer.cancer.gov\/report_to_nation\/stats.html\u3009 (accessed 5.30.25)."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib4","doi-asserted-by":"crossref","first-page":"W513","DOI":"10.1093\/nar\/gkae303","article-title":"ProTox 3.0: a webserver for the prediction of toxicity of chemicals","volume":"52","author":"Banerjee","year":"2024","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.compbiolchem.2025.108690_bib5","first-page":"5","article-title":"Aurora kinase inhibitors: current status and outlook","author":"Bavetsias","year":"2015","journal-title":"Front Oncol."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2025.108447","article-title":"Exploring spirocyclic isoquinoline-piperidine compounds in tuberculosis therapy: ADMET profiling, docking, DFT, MD simulations, and MMGBSA analysis","volume":"118","author":"Bellapukonda","year":"2025","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib7","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s11094-021-02513-x","article-title":"Quantitative Structure\u2013Activity relationship analysis and validation of new DNA gyrase inhibitors","volume":"55","author":"Bhuvaneswari","year":"2021","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2017.08.045","article-title":"A comprehensive review on aurora kinase: small molecule inhibitors and clinical trial studies","volume":"140","author":"Borisa","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiolchem.2024.108134","article-title":"Targeting cyclin-dependent kinase 2 CDK2: insights from molecular docking and dynamics simulation \u2013 a systematic computational approach to discover novel cancer therapeutics","volume":"112","author":"Chagaleti","year":"2024","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s43088-024-00577-8","article-title":"Discovery of novel CDK2 inhibitors for cancer treatment: integrating ligand-based pharmacophore modelling, molecular docking, DFT, ADMET, and molecular dynamics simulation studies","volume":"13","author":"Chagaleti","year":"2024","journal-title":"Beni Suef Univ. J. Basic Appl. Sci."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.142009","article-title":"Pyrazolopyrimidine fused thiazolidinone hybrids as CDK2 inhibitors: insights from pharmacophore modeling, docking, DFT and molecular dynamics simulations","volume":"1336","author":"Chagaleti","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib12","doi-asserted-by":"crossref","first-page":"33770","DOI":"10.1039\/D3RA05672D","article-title":"Exploring cyclin-dependent kinase inhibitors: a comprehensive study in search of CDK-6 inhibitors using a pharmacophore modelling and dynamics approach","volume":"13","author":"Chagaleti","year":"2023","journal-title":"RSC Adv."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib13","unstructured":"Chemical Computing Group ULC, 2025. Molecular Operating Environment (MOE)."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib14","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1007\/s00432-016-2136-1","article-title":"The aurora kinase inhibitors in cancer research and therapy","volume":"142","author":"Cicenas","year":"2016","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib15","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/j.1747-0285.2008.00663.x","article-title":"Pharmacophore modelling and virtual screening for identification of new Aurora-A kinase inhibitors","volume":"71","author":"Deng","year":"2008","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030734","article-title":"Evolution of resistance to aurora kinase b inhibitors in leukaemia cells","volume":"7","author":"Failes","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.compbiolchem.2025.108690_bib17","unstructured":"Frisch M.J, T.G.W., et al., 2016. Gaussian 16 Revision A.03."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1517\/17460441.2015.1032936","article-title":"The MM\/PBSA and MM\/GBSA methods to estimate ligand-binding affinities","volume":"10","author":"Genheden","year":"2015","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib19","doi-asserted-by":"crossref","first-page":"7731","DOI":"10.1039\/c3cp00116d","article-title":"Comparison of MM\/GBSA calculations based on explicit and implicit solvent simulations","volume":"15","author":"Godschalk","year":"2013","journal-title":"Phys. Chem. Chem. Phys."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2015.00285","article-title":"A cell Biologist\u2019s field guide to aurora kinase inhibitors","volume":"5","author":"de Groot","year":"2015","journal-title":"Front. Oncol."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130913","article-title":"A comprehensive review on role of aurora kinase inhibitors (AKIs) in cancer therapeutics","volume":"265","author":"Gupta","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib22","unstructured":"IARC Cancer Tomorrow, Globocan, 2022. 1.1."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2025.142310","article-title":"Synthesis of novel N4-substituted and C2-disubstituted 1,4-benzothiazine-1,1-dioxide derivatives: integrative computational strategies for breast cancer therapy","volume":"1338","author":"Irrou","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ejmech.2018.03.064","article-title":"Design and synthesis of BPR1K653 derivatives targeting the back pocket of aurora kinases for selective isoform inhibition","volume":"151","author":"Ke","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib25","doi-asserted-by":"crossref","first-page":"W409","DOI":"10.1093\/nar\/gks378","article-title":"ZINCPharmer: pharmacophore search of the ZINC database","volume":"40","author":"Koes","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib26","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1007\/s10637-012-9798-6","article-title":"Aurora kinase inhibitors: progress towards the clinic","volume":"30","author":"Kollareddy","year":"2012","journal-title":"Invest N. Drugs"},{"key":"10.1016\/j.compbiolchem.2025.108690_bib27","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.2174\/0929867330666230503124408","article-title":"Recent updates on oncogenic signaling of aurora kinases in chemosensitive, chemoresistant cancers: novel medicinal chemistry approaches for targeting aurora kinases","volume":"31","author":"Kumari","year":"2024","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.140060","article-title":"Thymol-1,2,3-triazole derivatives: network pharmacology, molecular simulations and synthesis targeting breast cancer","volume":"1321","author":"Laamari","year":"2025","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.139116","article-title":"Multitargeted molecular docking and dynamics simulation of thymol-based chalcones against cancer protein markers: synthesis, characterization, and computational study","volume":"1317","author":"Laamari","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","article-title":"Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1","volume":"46","author":"Lipinski","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib31","doi-asserted-by":"crossref","first-page":"D198","DOI":"10.1093\/nar\/gkl999","article-title":"BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities","volume":"35","author":"Liu","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib32","doi-asserted-by":"crossref","first-page":"639","DOI":"10.18311\/jnr\/2025\/45930","article-title":"Exploring natural compound libraries for breast cancer targets: an <I>In Silico<\/I> study","author":"Mantharachalam","year":"2025","journal-title":"J. Nat. Remed."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib33","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.bmc.2010.11.064","article-title":"Computational approach to the identification of novel Aurora-A inhibitors","volume":"19","author":"Morshed","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2024.107460","article-title":"Identification of novel DNA gyrase inhibitor by combined pharmacophore modeling, QSAR analysis, molecular docking, molecular dynamics, ADMET and DFT approaches","volume":"260","author":"Moulishankar","year":"2024","journal-title":"Acta Trop."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.chphi.2024.100512","article-title":"Pharmacophore, QSAR, molecular docking, molecular dynamics and ADMET study of trisubstituted benzimidazole derivatives as potent anti-tubercular agents","volume":"8","author":"Moulishankar","year":"2024","journal-title":"Chem. Phys. Impact"},{"key":"10.1016\/j.compbiolchem.2025.108690_bib36","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1021\/jm300687e","article-title":"Directory of useful decoys, enhanced (DUD-E): better ligands and decoys for better benchmarking","volume":"55","author":"Mysinger","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib37","unstructured":"National Cancer Institute, Cancer Statistics, Cancer Statistics, 2024."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib38","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.3390\/cimb44100329","article-title":"Pharmacophore-Model-Based Virtual-Screening approaches identified novel natural molecular candidates for treating human neuroblastoma","volume":"44","author":"Opo","year":"2022","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib39","doi-asserted-by":"crossref","first-page":"4049","DOI":"10.1038\/s41598-021-83626-x","article-title":"Structure based pharmacophore modeling, virtual screening, molecular docking and ADMET approaches for identification of natural anti-cancer agents targeting XIAP protein","volume":"11","author":"Opo","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib40","doi-asserted-by":"crossref","first-page":"735","DOI":"10.5530\/jyp.2024.16.93","article-title":"Innovative thiophene schiff bases: synthesis and evaluation as antitubercular agents","volume":"16","author":"Paleti","year":"2024","journal-title":"J. Young. Pharm."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib41","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","article-title":"pkCSM: predicting Small-Molecule pharmacokinetic and toxicity properties using Graph-Based signatures","volume":"58","author":"Pires","year":"2015","journal-title":"J. Med Chem."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.134935","article-title":"A comprehension on synthetic strategies of aurora kinase a and b inhibitors","volume":"1278","author":"Priya","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/10799893.2020.1794004","article-title":"Lead optimization of 4-(thio)-chromenone 6- o -sulfamate analogs using QSAR, molecular docking and DFT \u2013 a combined approach as steroidal sulfatase inhibitors","volume":"41","author":"R","year":"2021","journal-title":"J. Recept. Signal Transduct."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib44","unstructured":"S, G., 2022. Molinspiration Cheminformatics Free Web Services."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib45","doi-asserted-by":"crossref","first-page":"4444","DOI":"10.1158\/0008-5472.CAN-22-1175","article-title":"Sustained aurora kinase b expression confers resistance to PI3K inhibition in head and neck squamous cell carcinoma","volume":"82","author":"Shah","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib46","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib47","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/07391102.2021.2004236","article-title":"Discovery of potential Aurora-A kinase inhibitors by 3D QSAR pharmacophore modeling, virtual screening, docking, and MD simulation studies","volume":"41","author":"Swamy P. M","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib49","doi-asserted-by":"crossref","first-page":"23937","DOI":"10.18632\/oncotarget.14893","article-title":"Aurora kinases: novel therapy targets in cancers","volume":"8","author":"Tang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.compbiolchem.2025.108690_bib50","doi-asserted-by":"crossref","first-page":"244","DOI":"10.5530\/jyp.2024.16.32","article-title":"2,4-Substituted oxazolones: antioxidant potential exploration","volume":"16","author":"Thanvi","year":"2024","journal-title":"J. Young.. Pharm."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib51","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/17460441.2025.2481272","article-title":"Advances in the design, discovery, and optimization of aurora kinase inhibitors as anticancer agents","volume":"20","author":"Verma","year":"2025","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib52","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1053\/j.seminoncol.2006.04.007","article-title":"Tubulin-Associated drug targets: aurora kinases, Polo-like kinases, and others","volume":"33","author":"Warner","year":"2006","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2023.136178","article-title":"Selective targeting of aurora kinase b over A: uncovering the structural basis for inhibitor specificity through molecular dynamics simulations","volume":"1292","author":"Zhao","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.compbiolchem.2025.108690_bib54","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1016\/j.apsb.2023.03.013","article-title":"Emerging roles of Aurora-A kinase in cancer therapy resistance","volume":"13","author":"Zheng","year":"2023","journal-title":"Acta Pharm. Sin. B"}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927125003512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927125003512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T03:26:32Z","timestamp":1765337192000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927125003512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":54,"alternative-id":["S1476927125003512"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108690","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting Aurora A kinase: Computational discovery of potent inhibitors through integrated pharmacophore and simulation approaches","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2025.108690","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108690"}}